Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 21, 2013, Pages 8662-8667

  Wiley, Devin T ^a   Webster, Paul ^b   Gale, Aaron ^a   Davis, Mark E ^a  

^a California Institute of Technology   (United States)

^b HOUSE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD NANOPARTICLE; SILVER; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; HYDRODYNAMICS; MOUSE; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; RECEPTOR BINDING; TRANSCYTOSIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; BLOOD-BRAIN BARRIER; ENDOTHELIAL CELLS; FEMALE; GOLD; HUMANS; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; RECEPTORS, TRANSFERRIN; TRANSCYTOSIS; TRANSFERRIN;

EID: 84878145752     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1307152110     Document Type: Article

References (23)

1. Neuwelt E, et al. (2008) Strategies to advance translational research into brain barriers. Lancet Neurol 7(1): 84-96.
2. Yu YJ, et al. (2011) Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med 3(84):84ra44.
3. Friden PM, Olson TS, Obar R, Walus LR, Putney SD (1996) Characterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor. J Pharmacol Exp Ther 278(3): 1491-1498.
4. Davis ME, Chen ZG, Shin DM (2008) Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat Rev Drug Discov 7(9): 771-782.
5. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC (2012) Targeted polymeric therapeutic nanoparticles: Design, development and clinical translation. Chem Soc Rev 41(7): 2971-3010.
6. Davis ME, et al. (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464(7291): 1067-1070.
7. Montet X, Funovics M, Montet-Abou K, Weissleder R, Josephson L (2006) Multivalent effects of RGD peptides obtained by nanoparticle display.J Med Chem49(20): 6087-6093.
8. Martinez-Veracoechea FJ, Frenkel D (2011) Designing super selectivity in multivalent nano-particle binding. Proc Natl Acad Sci USA 108(27): 10963-10968.
9. Choi CHJ, Alabi CA, Webster P, Davis ME (2010) Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc Natl Acad Sci USA 107(3): 1235-1240.
10. Nance EA, et al. (2012) A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med 4(149):149ra119.
11. Lockman PR, Koziara JM, Mumper RJ, Allen DD (2004) Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 12(9-10): 635-641.
12. Lundqvist M, et al. (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105(38): 14265-14270.
13. Xiao K, et al. (2011) The effect of surface charge on in vivo biodistribution of PEGoligocholic acid based micellar nanoparticles. Biomaterials 32(13): 3435-3446.
14. Davis ME (2009) The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: From concept to clinic. Mol Pharm 6(3): 659-668.
15. Dautry-Varsat A, Ciechanover A, Lodish HF (1983) pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci USA 80(8): 2258-2262.
16. Hou SY, Chen HK, Cheng HC, Huang CY (2007) Development of zeptomole and attomolar detection sensitivity of biotin-peptide using a dot-blot gold nanoparticle immunoassay. Anal Chem 79(3): 980-985.
17. Choi CHJ, Zuckerman JE, Webster P, Davis ME (2011) Targeting kidney mesangium by nanoparticles of defined size. Proc Natl Acad Sci USA 108(16): 6656-6661.
18. Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WCW (2009) Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett 9(5): 1909-1915.
19. Bellocq NC, Pun SH, Jensen GS, Davis ME (2003) Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem 14(6): 1122-1132.
20. Mangani S, Messori L (1992) EXAFS studies on copper transferrin. J Inorg Biochem 48: 33-40.
21. Armstrong JK, Wenby RB, Meiselman HJ, Fisher TC (2004) The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys J 87(6): 4259-4270.
22. Jiang W, Kim BYS, Rutka JT, Chan WCW (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3(3): 145-150.
23. Wolburg H, et al. (2008) Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat. Histochem Cell Biol 130(1): 127-140.